Logo
x

Search

Subscribe Now

Japan

Daiichi Sankyo and Kite’s Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy Receives MHRA’s Approval for the Treatment of Lymphoma in Japan

Daiichi Sankyo and Kite’s Yescarta (Axicabtagene Ciloleucel) CAR T-Cell Therapy Receives MHRA’s Approval for the Treatment of Lymp...

  • December 17, 2021
AstraZeneca's Saphnelo (anifrolumab) Receives MHLW's Approval for the Treatment of Systemic Lupus Erythematosus

AstraZeneca's Saphnelo (anifrolumab) Receives MHLW's Approval for the Treatment of Systemic Lupus Erythematosus

  • September 28, 2021
Takeda's Alofisel (darvadstrocel) Receives MHLW's Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildly Active Luminal CD

Takeda's Alofisel (darvadstrocel) Receives MHLW's Approval for the Treatment of Complex Perianal Fistulas with Non-active or Mildl...

  • September 27, 2021
Takeda Enters into an Exclusive License Agreement with Mirum to Develop and Commercialize Maralixibat for Rare Pediatric Liver Diseases in Japan

Takeda Enters into an Exclusive License Agreement with Mirum to Develop and Commercialize Maralixibat for Rare Pediatric Liver Dis...

  • September 22, 2021
AM-Pharma Enters into an Exclusive License Agreement with Kyowa Kirin to Commercialize Ilofotase Alfa in Japan

AM-Pharma Enters into an Exclusive License Agreement with Kyowa Kirin to Commercialize Ilofotase Alfa in Japan

  • September 8, 2021
Celltrion's Herzuma (biosimilar- trastuzumab) Overtook the Original Treatments for Cancer

Celltrion's Herzuma (biosimilar- trastuzumab) Overtook the Original Treatments for Cancer

  • August 11, 2021
Merck Reports Top-line Data from the P-III (V503-064) Study of Gardasil 9 in Japanese Males

    Merck Reports Top-line Data from the P-III (V503-064) Study of Gardasil 9 in Japanese Males

    • September 12, 2024
    AstraZeneca’s Fasenra Receives NMPA’s Approval to Treat Severe Eosinophilic Asthma

      AstraZeneca’s Fasenra Receives NMPA’s Approval to Treat Severe Eosinophilic Asthma

      • August 21, 2024
      Ipsen Reports Collaboration Expansion with Exelixis to Develop Cabometyx for Treating Neuroendocrine Tumors

        Ipsen Reports Collaboration Expansion with Exelixis to Develop Cabometyx for Treating Neuroendocrine Tumors

        • July 2, 2024
        Unlocking Approval: Moitreyee Chatterjee-Kishore from Astellas & Kohei Shitara in Conversation with PharmaShots

          Unlocking Approval: Moitreyee Chatterjee-Kishore from Astellas & Kohei Shitara in Conversation with PharmaShots

          • June 24, 2024
          AstraZeneca’s Truqap in Combination with Faslodex Receives EC’s Approval for Treating Breast Cancer

            AstraZeneca’s Truqap in Combination with Faslodex Receives EC’s Approval for Treating Breast Cancer

            • June 20, 2024
            Saghmos Therapeutics Receives the US Patent for ST-62516 to Reduce the Risk of Acute Kidney Injury

              Saghmos Therapeutics Receives the US Patent for ST-62516 to Reduce the Risk of Acute Kidney Injury

              • June 6, 2024
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.